Acelyrin, Inc. (SLRN) Tops Q2 EPS by 22c
Acelyrin, Inc. (NASDAQ: SLRN) reported Q2 EPS of ($0.86), $0.22 better than the analyst estimate of ($1.08).
For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.
Acelyrin, Inc. (NASDAQ: SLRN) reported Q2 EPS of ($0.86), $0.22 better than the analyst estimate of ($1.08).
For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.